Patient P-01527
Synthetic patientNBL-101 · Day 93 · 45–54 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
17%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S17
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-8
- Nutritional resilience+4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion18.4/100
improving · -14.0 vs previous 14 d
Toxicity
Blood21.1/100
improving · -11.1 vs previous 14 d
Sleep quality
Wearable45.5/100
improving · +4.5 vs previous 14 d
Energy level
Daily log5.6/10
improving · +1.1 vs previous 14 d
Stress level
Daily log4.1/10
improving · -1.1 vs previous 14 d
Steps
Wearable3,946
improving · +1,243 vs previous 14 d
Adherence
Companion85.5 %
stable · -0.3 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 76 from the failing basin, 14 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Enterobacteriaceae elevatedhidden · steering -7.4
- IL6 high-expression varianthidden · steering -7.3
- Spicy / capsaicinperturbation · steering -5.5
- Poor-sleep weekperturbation · steering -3
- Spicy / capsaicindetractor · GI +3.6 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Spicy / capsaicin+3.6detractor · 90%
- Simple carbohydrates-1no signal · 20%
- Insoluble fibre-1no signal · 17%
- Dietary fat load-0.6no signal · 15%
- Histamine load-0.4no signal · 15%
- Alcohol-0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓40
- Wearable3,946 steps/day
- WearableShort sleep window
- Inflammatory signalling ↓25
- DNAIL6 -174 variant raises baseline inflammatory tone
- Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.6 · butyrate capacity 70/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 65 ms
- Sleep
- 6.4 h
- Steps
- 4,586
- Resting HR
- 67 bpm
Daily log: GI score 18, nutritional resilience 66, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.